Mechanism of acid-induced bone resorption

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 4, 2004, Pages 423-436

  Krieger, Nancy S ^a   Frick, Kevin K ^a   Bushinsky, David A ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

Acidosis; Bone resorption; Calcium; Prostaglandins; Proton

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CARBONIC ACID; MATRIX PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATE; POTASSIUM; PROSTAGLANDIN; SODIUM;

BONE MINERAL; CALCIUM TRANSPORT; CELL ACTIVITY; CELL PH; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; METABOLIC ACIDOSIS; MINERAL DEFICIENCY; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PARACRINE SIGNALING; PH MEASUREMENT; PHOSPHATE DEFICIENCY; POTASSIUM DEPLETION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN SYNTHESIS REGULATION; REVIEW; SODIUM DEPLETION;

ACIDOSIS; BONE DENSITY; BONE RESORPTION; BUFFERS; CALCIUM; CARRIER PROTEINS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYDROGEN; HYDROGEN-ION CONCENTRATION; KIDNEY DISEASES; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; PROSTAGLANDINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 3142622907     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000133975.32559.6b     Document Type: Review

References (143)

1. Bushinsky DA. Metabolic acidosis. In: Jacobson HR, Striker GE, Klahr S, editors. The principles and practice of nephrology. St. Louis, MO: Mosby; 1995. pp. 924-932.
2. Bushinsky DA. Internal exchanges of hydrogen ions: bone. In: Seldin DW, Giebisch G, editors. The regulation of acid-base balance. New York: Raven Press; 1989. pp. 69-88.
3. Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995; 47:1816-1832.
4. Lemann J Jr, Bushinsky DA, Hamm LL. Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 2003; 285:F811-F832. This is a comprehensive review of current understanding of bone buffering.
5. Bushinsky DA, Krieger NS. Integration of calcium metabolism in the adult. In: Coe FL, Favus MJ, editors. Disorders of bone and mineral metabolism. New York: Raven Press; 1992. pp. 417-432.
6. Bushinsky DA, Krieger NS. Role of the skeleton in calcium homeostasis. In: Seldin DW, Giebisch G, editors. The kidney: physiology and pathophysiology. New York: Raven Press; 1992. pp. 2395-2430.
7. Bushinsky DA. Acid-base imbalance and the skeleton. Eur J Nutr 2001; 40:238-244.
8. Bushinsky DA. Hydrogen ions. In: Bushinsky DA, editor. Renal osteodystrophy. Philadelphia: Lippincott-Raven; 1998. pp. 103-127.
9. Bushinsky DA. Acid-base imbalance and the skeleton. In: Burckhardt P, Dawson-Hughes B, Heaney RP, editors. Nutritional aspects of osteoporosis. Norwell, Massachusetts: Serono Symposia USA; 1998. pp. 208-217.
10. Madias NE, Kraut JA. Uremic acidosis. In: Seldin DW, Giebisch G, editors. The regulation of acid-base balance. New York: Raven Press; 1989. pp. 285-317.
11. Batlle DC. Renal tubular acidosis. In: Seldin DW, Giebisch G, editors. The regulation of acid-base balance. New York: Raven Press; 1989. pp. 353-390.
12. Goodman AD, Lemann J Jr, Lennon EJ, Relman AS. Production, excretion, and net balance of fixed acid in patients with renal acidosis. J Clin Invest 1965; 44:495-506.
13. Litzow JR, Lemann J Jr, Lennon EJ. The effect of treatment of acidosis on calcium balance in patients with chronic azotemic renal disease. J Clin Invest 1967; 46:280-286.
14. Mora Palma FJ, Ellis HA, Cook DB, et al. Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Q J Med 1983; 52:332-348.
15. Levitt MF, Turner LB, Sweet AY, Pandiri D. The response of bone, connective tissue, and muscle to acute acidosis. J Clin Invest 1956; 35:98-105.
16. 2 tension or extra-cellular bicarbonate concentration. J Clin Invest 1965; 44:8-20.
17. + of cardiac and skeletal muscle in acidosis and alkalosis. Am J Physiol 1975; 229:1305-1310.
18. Bushinsky DA, Krieger NS. Regulation of bone formation and dissolution. In: Coe F, Favus M, Pak C, Parks J, Preminger G, editors. Kidney stones: medical and surgical management. New York: Raven Press; 1996. pp. 239-258.
19. Bushinsky DA. Acidosis and bone. Miner Electrolyte Metab 1994; 20:40-52.
20. Bushinsky DA, Ori Y. Effects of metabolic and respiratory acidosis on bone. Curr Opin Nephrol Hypertens 1993; 2:588-596.
21. Bushinsky DA, Lam BC, Nespeca R, et al. Decreased bone carbonate content in response to metabolic, but not respiratory, acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 34) 1993; 265:F530-F536.
22. Bushinsky DA. Net proton influx into bone during metabolic, but not respiratory, acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 23) 1988; 254:F306-F310.
23. Bushinsky DA. Effects of parathyroid hormone on net proton flux from neonatal mouse calvariae. Am J Physiol (Renal Fluid Electrolyte Physiol 21) 1987; 252:F585-F589.
24. Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution. Am J Physiol (Renal Fluid Electrolyte Physiol 22) 1987; 253:F998-F1005.
25. Bushinsky DA, Krieger NS, Geisser DI, et al. Effects of pH on bone calcium and proton fluxes in vitro. Am J Physiol (Renal Fluid Electrolyte Physiol 14) 1983; 245:F204-F209.
26. Bushinsky DA, Levi-Setti R, Coe FL. Ion microprobe determination of bone surface elements: effects of reduced medium pH. Am J Physiol (Renal Fluid Electrolyte Physiol 19) 1986; 250:F1090-F1097.
27. Bushinsky DA, Wolbach W, Sessler NE, et al. Physicochemical effects of acidosis on bone calcium flux and surface ion composition. J Bone Miner Res 1993; 8:93-102.
28. Bergstrom WH, Ruva FD. Changes in bone sodium during acute acidosis in the rat. Am J Physiol 1960; 198:1126-1128.
29. Bettice JA, Gamble JL Jr. Skeletal buffering of acute metabolic acidosis. Am J Physiol 1975; 229:1618-1624.
30. Burnell JM. Changes in bone sodium and carbonate in metabolic acidosis and alkalosis in the dog. J Clin Invest 1971; 50:327-331.
31. Bushinsky DA, Gavrilov K, Stathopoulos VM, et al. Effects of osteoclastic resorption on bone surface ion composition. Am J Physiol (Cell Physiol 40) 1996; 271:C1025-C1031.
32. Bushinsky DA, Gavrilov K, Chabala JM, et al. Effect of metabolic acidosis on the potassium content of bone. J Bone Miner Res 1997; 12:1664-1671.
33. Bettice JA. Skeletal carbon dioxide stores during metabolic acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 16) 1984; 247:F326-F330.
34. Kraut JA, Mishler DR, Kurokawa K. Effect of colchicine and calcitonin on calcemic response to metabolic acidosis. Kidney Int 1984; 25:608-612.
35. Pellegrino ED, Blitz RM, Letteri JM. Inter-relationships of carbonate, phosphate, monohydrogen phosphate, calcium, magnesium, and sodium in uraemic bone: comparison of dialyzed and non-dialyzed patients. Clin Sci Mol Med 1977; 53:307-316.
36. Kaye M, Frueth AJ, Silverman M. A study of vertebral bone powder from patients with chronic renal failure. J Clin Invest 1970; 49:442-453.
37. Pellegrino ED, Blitz RM. The composition of human bone in uremia. Medicine 1965; 44:397-418.
38. Barzel US. The skeleton as an ion exchange system: Implications for the role of acid-base imbalance in the genesis of osteoporosis. J Bone Miner Res 1995; 10:1431-1436.
39. 3 response to low calcium diet. Am J Physiol (Renal Fluid Electrolyte Physiol 12) 1982; 243:F570-F575.
40. Lemann J Jr, Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 1966; 45:1608-1614.
41. Lemann J Jr, Litzow JR, Lennon EJ. Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J Clin Invest 1967; 46:1318-1328.
42. Green J, Kleeman CR. Role of bone in regulation of systemic acid-base balance. Kidney Int 1991; 39:9-26.
43. Coe FL, Bushinsky DA. Pathophysiology of hypercalciuria. Am J Physiol (Renal Fluid Electrolyte Physiol) 1984; 247:F1-F13.
44. 3 to variation of ionized calcium during chronic acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 18) 1985; 249:F361-365.
45. Bleich HL, Moore MJ, Lemann J Jr, Adams ND, Gray RW. Urinary calcium excretion in human beings. N Engl J Med 1979; 301:535-541.
46. Widdowson EM, McCance RA, Spray CM. The chemical composition of the human body. Clin Sci 1951; 10:113-125.
47. Widdowson EM, Dickerson JWT. Chemical composition of the body. In: Comar CL, Bronner F, editors. Mineral metabolism. New York: Academic Press, Inc.; 1964. pp. 1-247.
48. Kraut JA, Mishler DR, Singer FR, Goodman WG. The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int 1986; 30:694-700.
49. Bishop MC, Ledingham JG. Alkali treatment of renal osteodystrophy. BMJ 1972; 4:529.
50. Cocnran M, Wilkinson R. Effect of correction of metabolic acidosis on bone mineralization rates in patients with renal osteomalacia. Nephron 1975; 15:98-110.
51. Lefebvre A, de Vernejoul MC, Gueris J, et al. Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989; 36:1112-1118.
52. Lennon EJ, Lemann J Jr, Litzow JR. The effects of diet and stool composition on the net external acid balance of normal subjects. J Clin Invest 1966; 45:1601-1607.
53. Barzel US, editor. The role of bone in acid base metabolism. In: Osteoporosis. New York: Grune and Stratton; 1970. pp. 199-206.
54. Barzel US, editor. Osteoporosis II: an overview. In: Osteoporosis II. New York: Grune and Stratton; 1976. p. 1.
55. Lemann J Jr, Gray RW, Pleuss JA. Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. Kidney Int 1989; 35:688-695.
56. Sebastian A, Harris ST, Ottaway JH, et al. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 1994; 330:1776-1781.
57. Sakhaee K, Nicar M, Hill K, Pak CY. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 1983; 24:348-352.
58. Young MF, Kerr JM, Ibaraki K, et al. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res 1992; 281:275-294.
59. Marsh ME, Muune AM, Vogel JJ, et al. Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts. J Bone Miner Res 1995; 10:1635-1643.
60. McSherry E, Morris RC. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 1978; 61:509-527.
61. McSherry E. Acidosis and growth in nonuremic renal disease. Kidney Int 1978; 14:349-354.
62. Challa A, Krieg RJ Jr, Thabet MA, et al. Metabolic acidosis inhibits growth hormone secretion in rats: mechanism of growth retardation. Am J Physiol 1993; 265:E547-E553.
63. Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med 1982; 307:217-221.
64. Neuman WF, Neuman MW. The chemical dynamics of bone mineral. Chicago: University Chicago Press; 1958.
65. Dominguez JH, Raisz LG. Effects of changing hydrogen ion, carbonic acid, and bicarbonate concentrations on bone resorption in vitro. Calcif Tiss Int 1979; 29:7-13.
66. 2-stimulated bone resorption. A correlative morphometric and biochemical analysis. Lab Invest 1980; 42:290-295.
67. Feldman RS, Krieger NS, Tashjian AH Jr. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro. Endocrinology 1980; 107:1137-1143.
68. Stern PH, Raisz LG. Organ culture of bone. In: Simmons DJ, Kunin AS, editors. Skeletal research. New York: Academic Press; 1979. pp. 21-59.
69. Bushinsky DA, Goldring JM, Coe FL. Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae. Am J Physiol (Renal Fluid Electrolyte Physiol 17) 1985; 248:F785-F789.
70. Bushinsky DA. Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 25) 1989; 256:F836-F842.
71. Chabala JM, Levi-Setti R, Bushinsky DA. Alteration in surface ion composition of cultured bone during metabolic, but not respiratory, acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 30) 1991; 261:F76-F84.
72. Bushinsky DA, Sessler NE, Krieger NS. Greater unidirectional calcium efflux from bone during metabolic, compared with respiratory, acidosis. Am J Physiol (Renal Fluid Electrolyte Physiol 31) 1992; 262:F425-F431.
73. Krieger NS, Sessler NE, Bushinsky DA. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol (Renal Fluid Electrolyte Physiol 31) 1992; 262:F442-F448.
74. Bushinsky DA, Sessler NE. Critical role of bicarbonate in calcium release from bone. Am J Physiol (Renal Fluid Electrolyte Physiol 32) 1992; 263: F510-F515.
75. Bushinsky DA, Sessler NE, Glena RE, Featherstone JDB. Proton-induced physicochemical calcium release from ceramic apatite disks. J Bone Miner Res 1994; 9:213-220.
76. Sprague SM, Krieger NS, Bushinsky DA. Greater inhibition of in vitro bone mineralization with metabolic than respiratory acidosis. Kidney Int 1994; 46:1199-1206.
77. Bushinsky DA. Stimulated osteoclastic and suppressed osteoblastic activity in metabolic but not respiratory acidosis. Am J Physiol (Cell Physiol 37) 1995; 268:C80-C88.
78. Ori Y, Lee SG, Krieger NS, Bushinsky DA. Osteoblastic intracellular pH and calcium in metabolic and respiratory acidosis. Kidney lnt 1995; 47:1790-1796.
79. Bushinsky DA, Nilsson EL. Additive effects of acidosis and parathyroid hormone on mouse osteoblastic and osteoclastic function. Am J Physiol (Cell Physiol 38) 1995; 269:C1364-C1370.
80. Bushinsky DA. Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts. Am J Physiol (Renal Fluid Electrolyte Physiol 40) 1996; 271:F216-F222.
81. 3 in the rat. Am J Physiol (Endocrinol Metab Physiol 20) 1989; 257:E578-E582.
82. Ellies LG, Nelson DGA, Featherstone JDB. Crystallographic structure and surface morphology of sintered carbonated apatites. J Biomed Mater Res 1988; 22:541-553.
83. Ellies LG, Carter JM, Natiella JR, et al. Quantitative analysis of early in vivo tissue response to synthetic apatite implants. J Biomed Mater Res 1988; 22:137-148.
84. Nelson DGA, Featherstone JDB, Duncan JF, Cutress TW. Effect of carbonate and fluoride on the dissolution behavior of synthetic apatites. Caries Res 1983; 17:200-211.
85. Nelson DGA, Featherstone JDB. Preparation, analysis and characterization of carbonated apatites. Calcif Tiss Int 1982; 34 (Suppl. 2):S69-S81.
86. Featherstone JDB, Pearson S, LeGeros RZ. An infrared method for quantification of carbonate in carbonated apatites. Caries Res 1984; 18:63-66.
87. Nelson DGA, Barry JC, Shields CP, et al. Crystal morphology, composition, and dissolution behavior of carbonated apatites prepared at controlled pH and temperature. J Colloid Interface Sci 1989; 130:467-479.
88. Featherstone JDB, Nelson DGA. Recent uses of electron microscopy in the study of physico-chemical processes affecting the reactivity of synthetic and biological apatites. Scanning Microsc 1989; 3:815-828.
89. Boskey AL, Posner AS. Conversion of amorphous calcium phosphate to microcrystalline hydroxyapatite-pH-dependent, solution mediated, solid-solid conversion. J Phys Chem 1973; 77:2313-2317.
90. Grynpas MD, Bonar LC, Glimcher MJ. Failure to detect an amorphous calcium-phosphate solid phase in bone mineral. A radial distribution function study. Calcif Tissue Int 1984; 36:291-301.
91. Bushinsky DA, Smith SB, Gavrilov KL, et al. Chronic acidosis-induced alteration in bone bicarbonate and phosphate. Am J Physiol Renal Physiol 2003; 285:F532-F539. This paper examines the changes in mineral bicarbonate and phosphate content that occur in response to acidosis.
92. Bushinsky DA, Smith SB, Gavrilov KL, et al. Acute acidosis-induced alteration in bone bicarbonate and phosphate. Am J Physiol Renal Physiol 2002; 283:F1091-F1097.
93. 3. Am J Physiol (Endocrinol Metab Physiol 20) 1989; 257:E815-E822.
94. Bushinsky DA, Chabala JM, Levi-Setti R. Ion microprobe analysis of mouse calvariae in vitro: evidence for a "bone membrane". Am J Physiol (Endocrinol Metab 19) 1989; 256:E152-E158.
95. 44Ca labeling of bone by scanning ion microprobe. Am J Physiol (Endocrinol Metab 22) 1990; 259:E586-E592.
96. 2-titration curves in acute hypercapnia obtained with a modified titration technique. J Appl Physiol 1980; 48:197-201.
97. Frick KK, Jiang L, Bushinsky DA. Acute metabolic acidosis inhibits the induction of osteoblastic egr-1 and type 1 collagen. Am J Physiol (Cell Physiol 41) 1997; 272:C1450-C1456.
98. Frick KK, Bushinsky DA. Chronic metabolic acidosis reversibly inhibits extracellular matrix gene expression in mouse osteoblasts. Am J Physiol (Renal Physiol 44) 1998; 275:F840-F847.
99. Frick KK, Bushinsky DA. Metabolic acidosis stimulates RANK ligand RNA expression in bone through a cyclooxygenase dependent mechanism. J Bone Miner Res 2003; 18:1317-1325. This paper demonstrates that acidosis stimulates RANKL in a prostaglandin-mediated manner, providing a mechanism for subsequent stimulation of bone resorption in response to acidosis.
100. Bhargava U, Bar-Lev M, Bellows CG, Aubin JE. Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 1988; 9:155-163.
101. Ecarot-Charrier B, Glorieux FH, Van Der Rest M, Pereira G. Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J Cell Biol 1983; 96:639-643.
102. Sudo H, Kodama HA, Amagai Y, et al. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983; 96:191-198.
103. Sprague SM, Krieger NS, Bushinsky DA. Aluminum inhibits bone nodule formation and calcification in vitro. Am J Physiol (Renal Fluid Electrolyte Physiol 33) 1993; 264:F882-F890.
104. Goodman WG, Coburn JW, Slatopolsky E, Salusky IB. Renal osteodystrophy in adults and children. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, ed 4. Philadelphia: Lippincott-Raven; 1999. pp. 347-363.
105. Slatopolsky E, Delmez J. Bone disease in chronic renal failure and after renal transplantation. In: Coe F, Favus M, editors. Disorders of bone and mineral metabolism. New York, NY: Raven Press; 1992. pp. 905-934.
106. 2 in mediating the effects of pH on the hydroosmotic response to vasopressin in the toad urinary bladder. J Clin Invest 1982; 69:499-506.
107. Frazier LW, Yorio T. Prostaglandins as mediators of acidification in the urinary bladder of Bufo marinus. Proc Soc Exp Biol Med 1990; 194:10-15.
108. Jones ER, Beck TR, Kapoor S, et al. Prostaglandins inhibit renal ammoniagenesis in the rat. J Clin Invest 1984; 74:992-1002.
109. Aalkjaer C, Peng HL. pH and smooth muscle. Acta Physiol Scand 1997; 161:557-566.
110. Raisz LG. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 1995; 125 (Suppl 7):2024S-2027S.
111. + stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol (Endocrinol Metab 16) 1987; 253:E90-E98.
112. Krieger NS, Parker WR, Alexander KM, Bushinsky DA. Prostaglandins regulate acid-induced cell-mediated bone resorption. Am J Physiol Renal Physiol 2000; 279:F1077-F1082.
113. Krieger NS, Frick KK, Bushinsky DA. Cortisol inhibits acid-induced bone resorption in vitro. J Am Soc Nephrol 2002; 13:2534-2539.
114. 2: a critical summary. Meth Enzymol 1982; 86:436-464.
115. Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992; 263:F181-F191.
116. Pilbeam CC, Kawaguchi H, Hakeda Y, et al. Differential regulation of the inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 1993; 268:25643-25649.
117. 2 in cultured neonatal mouse calvariae. Endocrinology 1994; 135:1157-1164.
118. Tetradis S, Pilbeam CC, Liu Y, Kream BE. Parathyroid hormone induces prostaglandin G/H synthase-2 expression by a cyclic adenosine 3′,5′-monophosphate-mediated pathway in the murine osteoblastic cell line MC3T3-E1. Endocrinology 1996; 137:5435-5440.
119. Tai H, Miyaura C, Pilbeam CC, et al. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology 1997; 138:2372-2379.
120. Pilbeam CC, Kawaguchi H, Voznesensky O, et al. Regulation of inducible prostaglandin G/H synthase by interleukin-1, transforming growth factors-α and -β, and prostaglandins in bone cells. Adv Exp Med Biol 1997; 4008:617-623.
121. 2 induction in neonatal mouse parietal bone cultures. J Bone Miner Res 1996; 11:358-366.
122. Kawaguchi H, Pilbeam CC, Gronowicz G, et al. Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 1995; 96:923-930.
123. O'Neill GP, Kennedy BP, Mancini JA, et al. Selective inhibitors of COX-2. Agents Actions Suppl 1995; 46:159-168.
124. Krieger NS, Hefley TJ. Differential effects of parathyroid hormone on protein phosphorylation in two osteoblast-like cell populations isolated from neonatal mouse calvaria. Calcif Tiss Int 1989; 44:192-199.
125. Stein GS, Lian JB, Stein JL, et al. Transcriptional control of osteoblast growth and differentiation [Review]. Physiol Rev 1996; 76:593-629.
126. Davies JE. In vitro modeling of the bone/implant interface. Anat Rec 1996; 245:426-445.
127. Rodan GA. Osteopontin overview. Ann NY Acad Sci 1995; 760:1-5.
128. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69:990-1047.
129. Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrinol Rev 1999; 20:345-357.
130. Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 2000; 11:905-913.
131. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin in bone cell biology. J Mol Med 2001; 79:243-253.
132. Horowitz MC, Xi Y, Wilson K, Kacena MA. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001; 12:9-18.
133. Ludwig MG, Vanek M, Gueirine D, et al. Proton-sensing G-protein-coupled receptors. Nature 2003; 425:93-98. This is the first report of a specific membrane receptor for protons.
134. Bektas M, Barak LS, Jolly PS, et al. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. Biochemistry 2003; 42:12181-12191.
135. Canzanello VJ, Bodvarsson M, Kraut JA, et al. Effect of chronic respiratory acidosis on urinary calcium excretion in the dog. Kidney Int 1990; 38:409-416.
136. Lau K, Rodriquez Nichols F, Tannen RL. Renal excretion of divalent tons in response to chronic acidosis: evidence that systemic pH is not the controlling variable. J Lab Clin Med 1987; 109:27-33.
137. 2 fractions, calcium, and phosphorus during chronic hypercapnia. J Appl Physiol 1980; 48:802-811.
138. 2 levels and calcium release. Am J Physiol (Renal Fluid Electrolyte Physiol) 2001; 281:F1058-F1066.
139. Frick KK, Bushinsky DA. In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression. Am J Physiol (Renal Physiol 46) 1999; 277:F750-F755.
140. Bushinsky DA, Sprague SM, Hallegot P, et al. Effects of aluminum on bone surface ion composition. J Bone Miner Res 1995; 10:1988-1997.
141. Bushinsky DA, Chabala JM, Gavrilov KL, Levi-Setti R. Effects of in vivo metabolic acidosis on midcortical bone ion composition. Am J Physiol (Renal Physiol 46) 1999; 277:F813-F819.
142. Glimcher MJ. The nature of the mineral component of bone and the mechanism of calcification. Instr Course Lectures 1987; 36:49-69.
143. Glimcher MJ. Composition, structure and organization of bone and other mineralized tissues, and the mechanism of calcification. In: Greep RO, Astwood EB, Aurbach GD, editors. Handbook of physiology, endocrinology. Washington: American Physiological Society; 1976. pp. 25-116.